Related Experiment Video
Updated: Jan 9, 2026

11:55
Membrane Transport Processes Analyzed by a Highly Parallel Nanopore Chip System at Single Protein Resolution
Published on: August 16, 2016
12.1K
Liposome array on a power-free microfluidic device for analysis of nanopore formation
Maho Hosokawa1, Yiting Zhang1, Masaki Ohtawa1
1Department of Chemistry, College of Science, Rikkyo University, 3-34-1 Nishi-Ikebukuro, Toshima, Tokyo 171-8501, Japan. i_show@rikkyo.ac.jp.
The Analyst
|December 8, 2025
Summary
Researchers developed a new liposome sensing system using amphotericin B (AmB) and ergosterol to detect nanopore formation. This method screens compounds affecting membrane permeability, aiding drug discovery.
Area of Science:
- Biophysics
- Nanotechnology
- Drug Discovery
Background:
- Liposome-based sensing technology utilizing nanopore formation is a significant area of research.
- Understanding the interaction between amphotericin B (AmB) and ergosterol is crucial for liposomal membrane analysis.
Purpose of the Study:
- To analyze nanopore formation characteristics on liposomal membranes resulting from AmB-ergosterol interactions.
- To propose and demonstrate a novel system for examining nanopore formation and its modulation by compounds like shodoamide C (ShC).
Main Methods:
- Liposomes were prepared using a water-in-oil-in-water emulsion method.
- A microfluidic device with power-free pumping was employed for liposome introduction.
- Nanopore formation and molecular release kinetics were analyzed by varying ergosterol mole fraction, AmB concentration, and ShC presence.
Main Results:
- AmB binding to ergosterol induced nanopore formation, enabling encapsulated molecule release.
- Release time was controllable by adjusting membrane composition (ergosterol) and AmB concentration.
- Shodoamide C (ShC) was shown to enhance AmB activity by increasing membrane permeability and accelerating molecular release.
Conclusions:
- A novel analytical system was developed to measure AmB activity and the effects of enhancers/inhibitors via concentration-dependent release profiles.
- This system offers a practical tool for screening membrane-active compounds.
- The findings open new avenues for developing membrane-active therapeutics and advancing drug discovery and synthetic biology.

